EnVVeno Medical Corporation (NASDAQ:NVNO) | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

BRIEF

published on 11/20/2024 at 14:35, 1 day ago

EnVVeno Medical Unveils One-Year VenoValve Trial Results

Clinical Trial VenoValve Health Outcomes FDA Application CVI Treatment
PRESS RELEASE

published on 11/20/2024 at 14:30, 1 day ago

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
enVVeno Medical presents one-year data on VenoValve U.S. pivotal trial at VEITH Symposium supporting FDA pre-market authorization application. Study shows significant clinical benefits and safety profile

EnVVeno Medical VenoValve FDA Application Pivotal Trial VEITH Symposium
BRIEF

published on 11/19/2024 at 14:20, 2 days ago

EnVVeno Medical Seeks FDA Approval for VenoValve

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency PMA Application
PRESS RELEASE

published on 11/19/2024 at 14:15, 2 days ago

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
enVVeno to present definitive one year data from PMA application at 51st VEITH Symposium. Company aims for FDA approval to market VenoValve in the US

FDA Approval VenoValve CVI PMA Application EnVVeno
BRIEF

published on 10/31/2024 at 13:40, 21 days ago

EnVVeno Medical's Q3 2024 Financials and Upcoming FDA Milestones

Financial Results FDA Approval Clinical Trials VenoValve EnVVe Progress
PRESS RELEASE

published on 10/31/2024 at 13:35, 21 days 1 hour ago

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
enVVeno Medical Corporation reports progress towards FDA PMA approval for VenoValve and enVVe transcatheter-based valve replacement. Company ends quarter with $48.4M cash

Financial Results VenoValve Clinical Program FDA PMA Approval EnVVe Transcatheter Valve
BRIEF

published on 10/28/2024 at 13:35, 24 days 1 hour ago

EnVVeno Medical Commences Pre-Clinical Study for enVVe Valve

FDA Approval EnVVeno Medical CVI Treatment GLP Study EnVVe Valve
PRESS RELEASE

published on 10/28/2024 at 13:30, 24 days 1 hour ago

enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
enVVeno Medical Corporation successfully completes first wave of implants with updated delivery system for enVVe replacement venous valve, on track for U.S. pivotal trial in mid-2025

EnVVeno Medical Corporation Venous Disease Implants EnVVe Pivotal Trial
BRIEF

published on 09/27/2024 at 03:23, 1 month 24 days ago

EnVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering

Public Offering EnVVeno Medical VenoValve Venous Disease Titan Partners Group
PRESS RELEASE

published on 09/27/2024 at 03:18, 1 month 24 days ago

enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
enVVeno Medical Corporation announces pricing of underwritten public offering for the treatment of venous disease. Offering led by Titan Partners Group. Expected gross proceeds of $15.0 million

Public Offering Gross Proceeds EnVVeno Medical Corporation Venous Disease Titan Partners Group

1 2 ... 5

Accesswire

Published on 11/21/2024 at 14:15, 20 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 35 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 35 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 35 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 35 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 19 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 20 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 35 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 20 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 2 hours ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 37 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 15 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE